WASHINGTON (Reuters) -The U.S. House of Representatives on Monday began debate on a $900 billion coronavirus aid package meant to stimulate a pandemic-hit economy, which the leaders of both chambers of Congress aimed to pass in a marathon session.
U.S. President-elect Joe Biden received his first injected dose of the COVID-19 vaccine live on television on Monday in an effort to boost confidence in its safety ahead of its wide distribution next year.
NEW YORK (Reuters) -A gauge of equities around the world fell on Monday and oil prices plunged as concerns about a new coronavirus strain in Britain overshadowed optimism over a vaccine-fueled rebound in economic growth.
U.S. President-elect Joe Biden received his first dose of the Pfizer Inc COVID-19 vaccine on Monday at a hospital in Newark, Delaware, and he urged Americans to get the vaccine when it is available.
The Trump administration on Monday published a list of Chinese and Russian companies with alleged military ties that restrict them from buying a wide range of U.S. goods and technology.
NEW YORK (Reuters) -The S&P 500 closed lower on Monday, having clawed its way back from steep losses early in the session as investors juggled the outbreak of an ominous new strain of COVID-19 with the passage of a long-anticipated stimulus package.
Apple Inc is moving forward with self-driving car technology and is targeting 2024 to produce a passenger vehicle that could include its own breakthrough battery technology, people familiar with the matter told Reuters.
NEW YORK (Reuters) -Oil prices tumbled nearly 3% on Monday as a fast-spreading new coronavirus strain that has shut down much of Britain and led to tighter restrictions in Europe sparked worries about a slower recovery in fuel demand.
Total investor inflows into cryptocurrency funds and products hit $5.6 billion so far this year, up more than 600% from 2019, according to the latest data from asset manager CoinShares.
The European Union geared up to start mass vaccinations against COVID-19 just after Christmas after the shot developed by Pfizer and its German partner BioNTech cleared regulatory hurdles on Monday.
Fiat Chrysler and French rival PSA gained EU antitrust approval on Monday for their $38 billion merger to create the world's No.4 carmaker after pledging to boost Japanese rival Toyota Motor. Ciara Lee reports
